Spots Global Cancer Trial Database for Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Extension Study Investigating the Long-Term Safety of Degarelix Three-Month Depots in Patients With Prostate Cancer
Official Title: An Open-Label, Multi-Centre, Extension Study, Evaluating the Long-Term Safety and Tolerability of Different Three-Month Degarelix Dosing Regimens in Patients With Prostate Cancer
Study ID: NCT00268892
Conditions
Study Description
Brief Summary: The purpose of this extension study was to collect long-term safety and tolerability information to support a marketing authorisation application for a three-month dosage regimen of degarelix.
Detailed Description: The data include data from the participants who participated in both the main study FE200486 CS15 (NCT00113753) and the extension study FE200486 CS15A.
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: MALE
Healthy Volunteers: No
Locations
UZ Gasthuisberg Leuven, Leuven, , Belgium
Helsinki University Hospital, Maria Hospital, Building 11, Helsinki, , Finland
Central Hospital, North Karelian, Joensuu, , Finland
Oulu University Hospital, Oulu, , Finland
Tampere University Hospital, Tampere, , Finland
Fédération d'Urologie et Néphrologie, BP69 Hôpital Pasteur, Nice, , France
Gemeinschaftspraxis Dres Effert und Benedic, Aachen, , Germany
Clinical Center Novi Sad, Clinic of Urology, Novi Sad, , Montenegro
Academic Medical Center, Urology, Amsterdam, , Netherlands
St. Elisabeth Hospital, Tilburg, , Netherlands
"Centrul Medical Privat" Prof. Dr. Ioiart Ioan", Arad, , Romania
Clinical Hospital "Prof. Dr. Theodor Burghele", Urology Department, Bucharest, , Romania
University CF Hospital No. 2, Bucharest, , Romania
Andros Clinic, St. Petersburg, , Russian Federation
City Hospital #15, St. Petersburg, , Russian Federation
City Hospital #26, St. Petersburg, , Russian Federation
Pavlov State Medical University, Outpatient Diagnostic Center affiliated with the Urology Department, St. Petersburg, , Russian Federation
Pavlov State Medical University, Urology Department, St. Petersburg, , Russian Federation
Clinical Center of Serbia, Institute of Urology and Nephrology, Belgrade, , Serbia
Mount Vernon Cancer Centre, Marie Cuire Research Wing, Northwood, Middlesex, United Kingdom
Castle Hill Hospital, Hull, North Humberside, United Kingdom
Ward 13, NHS Forth Valley Acute Operating Division, Falkirk and District Royal Infirmary, Majors Loans, Falkirk, , United Kingdom
Level 7, Urology Research Unit, Derriford Hospital, Plymouth, , United Kingdom
Contact Details
Name: Clinical Development Support
Affiliation: Ferring Pharmaceuticals
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
